These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
926 related articles for article (PubMed ID: 28813705)
1. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382. Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705 [TBL] [Abstract][Full Text] [Related]
2. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p. Cao J; Han X; Qi X; Jin X; Li X Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349 [TBL] [Abstract][Full Text] [Related]
3. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p. Yan K; Tian J; Shi W; Xia H; Zhu Y Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446 [TBL] [Abstract][Full Text] [Related]
5. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1. He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway. Xu K; Zhang L Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615 [TBL] [Abstract][Full Text] [Related]
8. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer. Ma J; Zhang J; Weng YC; Wang JC Mol Cells; 2018 Sep; 41(9):868-880. PubMed ID: 30304920 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000 [TBL] [Abstract][Full Text] [Related]
10. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis. Xie C; Chen B; Wu B; Guo J; Cao Y Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327 [TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371 [TBL] [Abstract][Full Text] [Related]
12. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664 [TBL] [Abstract][Full Text] [Related]
13. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Lei H; Gao Y; Xu X Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764 [TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression. Shen J; Hong L; Yu D; Cao T; Zhou Z; He S Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263 [TBL] [Abstract][Full Text] [Related]
16. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079 [TBL] [Abstract][Full Text] [Related]
17. Silencing of the lncRNA Zhang B; Zhao C; Hou L; Wu Y Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of long noncoding RNA FERRE promoted growth and invasion of breast cancer through modulating miR-19a-5p/EZH2 axis. Lin Y; Wu T; Yang M; Duangmano S; Chaiwongsa R; Pornprasert S; He T Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11154-11164. PubMed ID: 33215433 [TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma. Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]